Characterization of arrhythmia substrate to ablate persistent atrial fibrillation (COAST-AF): Randomized controlled trial design and rationale

Pablo B. Nery; George A. Wells; Atul Verma; Jacqueline Joza; Girish M. Nair; George Veenhuyzen; Jason Andrade; Isabelle Nault; Jorge A. Wong; Markus Sikkel; Vidal Essebag; Laurent Macle; John Sapp; Jean Francois Roux; Allan Skanes; Paul Angaran; Paul Novak; Damian Redfearn; Mehrdad Golian; Calum J. Redpath; Marcio Sturmer; David Birnie

doi:10.1016/j.ahj.2022.08.010

Characterization of arrhythmia substrate to ablate persistent atrial fibrillation (COAST-AF): Randomized controlled trial design and rationale

Pablo B. Nery, George A. Wells, Atul Verma, Jacqueline Joza, Girish M. Nair, George Veenhuyzen, Jason Andrade, Isabelle Nault, Jorge A. Wong, Markus Sikkel, Vidal Essebag, Laurent Macle, John Sapp, Jean Francois Roux, Allan Skanes, Paul Angaran, Paul Novak, Damian Redfearn, Mehrdad Golian, Calum J. RedpathMarcio Sturmer, David Birnie

Research output: Contribution to journal › Article › peer-review

2 Citations (Scopus)

Original language	English
Pages (from-to)	133-140
Number of pages	8
Journal	American Heart Journal
Volume	254
DOIs	https://doi.org/10.1016/j.ahj.2022.08.010
Publication status	Published - Dec 2022
Externally published	Yes

ASJC Scopus Subject Areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.ahj.2022.08.010

Cite this

Nery, P. B., Wells, G. A., Verma, A., Joza, J., Nair, G. M., Veenhuyzen, G., Andrade, J., Nault, I., Wong, J. A., Sikkel, M., Essebag, V., Macle, L., Sapp, J., Roux, J. F., Skanes, A., Angaran, P., Novak, P., Redfearn, D., Golian, M., ... Birnie, D. (2022). Characterization of arrhythmia substrate to ablate persistent atrial fibrillation (COAST-AF): Randomized controlled trial design and rationale. American Heart Journal, 254, 133-140. https://doi.org/10.1016/j.ahj.2022.08.010

Nery, PB, Wells, GA, Verma, A, Joza, J, Nair, GM, Veenhuyzen, G, Andrade, J, Nault, I, Wong, JA, Sikkel, M, Essebag, V, Macle, L, Sapp, J, Roux, JF, Skanes, A, Angaran, P, Novak, P, Redfearn, D, Golian, M, Redpath, CJ, Sturmer, M & Birnie, D 2022, 'Characterization of arrhythmia substrate to ablate persistent atrial fibrillation (COAST-AF): Randomized controlled trial design and rationale', American Heart Journal, vol. 254, pp. 133-140. https://doi.org/10.1016/j.ahj.2022.08.010

@article{ef518d5626594dc599bae343532b9bf7,

title = "Characterization of arrhythmia substrate to ablate persistent atrial fibrillation (COAST-AF): Randomized controlled trial design and rationale",

author = "Nery, {Pablo B.} and Wells, {George A.} and Atul Verma and Jacqueline Joza and Nair, {Girish M.} and George Veenhuyzen and Jason Andrade and Isabelle Nault and Wong, {Jorge A.} and Markus Sikkel and Vidal Essebag and Laurent Macle and John Sapp and Roux, {Jean Francois} and Allan Skanes and Paul Angaran and Paul Novak and Damian Redfearn and Mehrdad Golian and Redpath, {Calum J.} and Marcio Sturmer and David Birnie",

note = "Publisher Copyright: {\textcopyright} 2022 Elsevier Inc.",

year = "2022",

month = dec,

doi = "10.1016/j.ahj.2022.08.010",

language = "English",

volume = "254",

pages = "133--140",

journal = "American Heart Journal",

issn = "0002-8703",

publisher = "Mosby Inc.",

}

TY - JOUR

T1 - Characterization of arrhythmia substrate to ablate persistent atrial fibrillation (COAST-AF)

T2 - Randomized controlled trial design and rationale

AU - Nery, Pablo B.

AU - Wells, George A.

AU - Verma, Atul

AU - Joza, Jacqueline

AU - Nair, Girish M.

AU - Veenhuyzen, George

AU - Andrade, Jason

AU - Nault, Isabelle

AU - Wong, Jorge A.

AU - Sikkel, Markus

AU - Essebag, Vidal

AU - Macle, Laurent

AU - Sapp, John

AU - Roux, Jean Francois

AU - Skanes, Allan

AU - Angaran, Paul

AU - Novak, Paul

AU - Redfearn, Damian

AU - Golian, Mehrdad

AU - Redpath, Calum J.

AU - Sturmer, Marcio

AU - Birnie, David

PY - 2022/12

Y1 - 2022/12

UR - http://www.scopus.com/inward/record.url?scp=85143916680&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85143916680&partnerID=8YFLogxK

U2 - 10.1016/j.ahj.2022.08.010

DO - 10.1016/j.ahj.2022.08.010

M3 - Article

C2 - 36030965

AN - SCOPUS:85143916680

SN - 0002-8703

VL - 254

SP - 133

EP - 140

JO - American Heart Journal

JF - American Heart Journal

ER -

Characterization of arrhythmia substrate to ablate persistent atrial fibrillation (COAST-AF): Randomized controlled trial design and rationale

ASJC Scopus Subject Areas

Access to Document

Other files and links

Fingerprint

Cite this